Chimeric Antigen Receptor (CAR)-Specific Monoclonal Antibody to Detect CD19-Specific T Cells in Clinical Trials

Clinical trials targeting CD19 on B-cell malignancies are underway with encouraging anti-tumor responses. Most infuse T cells genetically modified to express a chimeric antigen receptor (CAR) with specificity derived from the scFv region of a CD19-specific mouse monoclonal antibody (mAb, clone FMC63...

Descripción completa

Detalles Bibliográficos
Autores principales: Jena, Bipulendu, Maiti, Sourindra, Huls, Helen, Singh, Harjeet, Lee, Dean A., Champlin, Richard E., Cooper, Laurence J. N.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2013
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3585808/
https://www.ncbi.nlm.nih.gov/pubmed/23469246
http://dx.doi.org/10.1371/journal.pone.0057838

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3585808/
https://www.ncbi.nlm.nih.gov/pubmed/23469246
http://dx.doi.org/10.1371/journal.pone.0057838

Ejemplares similares